CTRI/2023/01/049023尚未招募未知
A prospective study to appraise the role of Immunological Biomarkers to predict the post operative outcomes of Epithelial Ovarian Carcinoma patients undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
il0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Patientâ??s requiring Upfront Cytoreductive Surgery and Interval
- •Cytoreduction after Chemotherapy
- •2. Cytology or Biopsy proven Epithelial Ovarian malignancies
- •3. Localized Metastasis on Imaging (CECT scans will be the most commonly
- •used investigation, as per institutional protocol)
- •4. Good Performance status (KPS-100-40 or ECOG -0-2)
- •5. Age >18 yrs < 70 years (extremes of age is to be avoided due to
- •anticipation of the morbidity of the surgery)
- •6. Preexisting co-morbid conditions that DONOT preclude CRS and HIPEC
- •7. ASA I to III
排除标准
- •1. Patient NOT consenting for Cytoreductive Surgery and HIPEC
- •2. Co morbidities that are a constant threat to the patientâ??s life
- •3. Poor performance Status and ASA IV and V
- •4. Study drop out
研究者
相似试验
进行中（未招募）
1 期
A forward-looking study to assess disease remission in patients with newly diagnosed blood cancer (multiple myeloma) who will be treated with a combination of three drugs followed by transplantation of own blood stem cells and maintainance therapy with one of the drugs (lenalidomide). Disease remission is measured with a method which can determine the presence of cancer cells in the bone marrow.Multiple myelomaEUCTR2012-001051-39-FIKuopio University Hospital, Clinic of Internal Medicine/Center of Medicine80
招募中
2 期
Exploratory study evaluating the potential of immune signature profiling for predicting response in patients with resectable Stage II, IIIA and select IIIB (T3N2 only) non-squamous Non-Small Cell Lung Cancer (NSCLC) to neoadjuvant ATEZOLIZUMAB plus Carboplatin/Nab PaclitaxelLung cancer2024-516590-75-00Universitaetsklinikum Heidelberg AöR, Universitaetsklinikum Heidelberg AöR20
进行中（未招募）
1 期
A study on the anti-inflammatory effects of azithromycin in tuberculosisPulmonary tuberculosisEUCTR2017-001929-40-NLniversity Medical Center Groningen24
招募中
2 期
A prospective, randomized pilot study of the immunomodulatory effects of azithromycin in adults with pulmonary tuberculosisTBTuberculosisNL-OMON47928niversitair Medisch Centrum Groningen24
进行中（未招募）
1 期
Evaluation of the benefits of Administering immunosuppressive drugs as Single daily doses over the first Year after liver transplantatiotransplantationCTIS2023-506601-19-00Centre Hospitalier Universitaire De Limoges200